1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 18, 2011
Grant Date -
Nov 5, 2009
app pub date -
Jul 20, 2009
filing date -
Apr 1, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to 1,3,4-oxadiazalones, compounds of formula I and their pharmaceutically acceptable salts stereoisomers, tautomers, or solvates thereof. Novel compounds include those of formula I, in which radicals are as defined herein.The compounds of this invention are modulators of PPARdelta and therefore useful as pharmaceutical agents, especially for the treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully